Adjuvant zoledronic acid reduces fractures in breast cancer patients: An AZURE (BIG 01/04) study

April 10, 2018

Adjuvant zoledronic acid reduces fractures in breast cancer patients: An AZURE (BIG 01/04) study

Published on 04/09/2018

previous post: Folfox or capox in stage II to III colon cancer: Efficacy results of the Italian Three or Six Colon Adjuvant Trial
next post: The clinicopathological significance of micropapillary pattern in colorectal cancers